PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Cancer Center

USPTO PatentsView assignee record — 183 granted patents across 42 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Explore the portfolio See the ranking
183
Total patents granted
42
CPC technology areas
9.1
Avg claims per patent
+95%
5-year filing velocity

The verdict

National holds 183 US patents across 42 technology areas — rank #2,158 of 50,000 tracked assignees.

#2,158
of 50,000 US assignees by volume
Top 8%
by Innovation Score (53.8/100)
9.1
avg claims per patent
+95%
filing velocity, last 5 yrs

Portfolio overview

National Cancer Center has been granted 183 US utility patents between 2015 and 2025, placing National Cancer Center at rank #2,158 across all assignees tracked by PlainPatent. This portfolio spans 42 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.1 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, National Cancer Center is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 121 grants, compared with 62 in the 2015–2019 window — a +95% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. National Cancer Center's 9.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 42 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark National Cancer Center against peers pursuing similar technology classes.

How does National compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows National holds 183 patents — placing it at rank #2,158 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

51015202530 20152016201720182019202020212022202320242025 20
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
National Cancer Center patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 12 6.6%
2016 10 5.5%
2017 14 7.7%
2018 13 7.1%
2019 13 7.1%
2020 26 14.2%
2021 15 8.2%
2022 22 12.0%
2023 14 7.7%
2024 24 13.1%
2025 20 10.9%

Which technologies does National Cancer Center patent most?

Top 15 of 42 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#2,158

Across all tracked assignees

Innovation Score

53.8 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does National Cancer Center hold?
National Cancer Center holds 183 US granted patents filed between 2015 and 2025, spanning 42 technology areas.
What is National Cancer Center's Innovation Score?
National Cancer Center has an Innovation Score of 53.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does National Cancer Center focus on?
National Cancer Center's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 76 patents. The company has filed patents in 42 CPC subclasses total.
Is National Cancer Center's patent filing rate increasing or decreasing?
National Cancer Center's recent filing velocity is +95% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for National Cancer Center's patents?
National Cancer Center's patents average 9.1 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the National Cancer Center patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

G01N technology

National Cancer Center's primary CPC class — all holders and yearly trends
Top 50 patent holders

See where National Cancer Center ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope